Persistent postoperative supraventricular tachycardia, despite adequate therapy, is a bad prognostic sign, and cardiac failure due to, or associated with, arrhythmia responds poorly to treatment. Of the 12 patients (24 per cent) resistent to therapy, eight developed congestive heart failure, with five dying as a result. The preoperative, intraoperative and postoperative factors contributing to the causes of this complication are reviewed, and the therapy, course and end results are discussed.
MATERIAL
The electrocardiograms taken at Memorial Center between Jan. 1, 1946 and Sept. 1, 1951, were excluded. Ventricular tachycardia was not encountered. The charts of these patients were reviewed, and the data classified according to the headings which precede each discussion.
OBSERVATIONS Incidence
Fifty patients developed supraventricular tachycardia during or within 18 days of operation. Four had second operations followed by recurrent arrhythmia, making a total of 54 instances of this complication. No instance of arrhythmia unconfirmed by electrocardiogram is included, although a number of these occurred during the period covered by this study. Hence, we cannot give the exact incidence of supraventricular tachycardia following operations done at Memorial Center, but it would appear to be well under 1 per cent, since approximately 28,000 operations were performed during this five and two-thirds year period. Thirty-one of the patients were males; adenomas of which two had once been toxic; three had emphysema; one, parkinsonism; and one was an alcoholic. Twenty patients exhibited no significant disease other than the surgical condition necessitating their hospital admission.
Preoperative Cardiac Status
Twenty-one patients (42 per cent) had no history or laboratory evidence of heart disease preoperatively. The most prevalent cardiovascular disease was essential hypertension, which was found in 19 patients (38 per cent). Arteriosclerotic heart disease was present in 10 patients (20 per cent); this was evidenced in seven (14 per cent) by a history of angina pectoris and in three (6 per cent) by a history of healed myocardial infarction. One patient had rheumatic heart disease (mitral stenosis); another had mild thyrotoxic heart disease and a third had noncyanotic congenital heart disease. Five patients (10 per cent) had had cardiac arrhythmias prior to their first operative procedure, although in two of these there was no other evidence of cardiac disease. All patients had normal sinus rhythm at the beginning of surgery, and none showed evidence of congestive failure.
Cardiac Cardiac arrhythmias developed during the operation in 11 instances (20.3 per cent). Five of these had received preoperative cardiac medication consisting of quinidine in two, digitalis in two, and Pronestyl in one. In one instance the abnormal rhythm subsided before completion of the operation. Cessation of the operation was required in two patients, the arrhythmia being associated with temporary cardiac arrest in one and with generalized convulsions in the other. Nine of these 11 patients had preoperative evidence of heart disease. The arrhythmia appeared to be precipitated by laryngoscopy in two instances, by gastric intubation and cardiac arrest in one each. In one patient the arrhythmia was just noted after a generalized convulsion and in the second it developed after pulmonary edema was established. In five instances, no apparent precipitating cause could be ascertained.
During the operation trauma to the heart and its environs was obviously associated with the onset of the arrhythmia in only three instances. Other fairly clear-cut etiologic events followed by rapid onset of arrhythmia included myocardial infarction in three patients, congestive heart failure in three, hypotension in three, pericarditis in two, cardiac arrest in one, pulmonary edema in one and digitalis toxicity in two. Less definite but possible causes were mediastinal shift in eight patients, pulmonary infarets in three, extensive atelectasis in three, bronchopneumonia in two, mediastinitis in two, bronchial stump leak in one and spontaneous pneumothorax in one. Incidental and less clearly associated complications included: abdominal distention, five; terminal cachexia, four; lower nephron nephrosis, two; peritonitis, two; septicemia, one; and transfusion reaction, one.
Miscellaneous Factors
The average oral temperature of the 43 patients who were febrile at the onset of arrhythmia was 102 F., with a range of 99 to 104 F. Seven patients were afebrile. The hemoglobin level within 24 hours of the occurrence of arrhythmia was below 12 Gm. per 100 cc. in 11 patients, 12 to 17 Gm. per 100 cc. in 34 patients and above 17 Gm. per 100 cc. in three; this datum was not available in two patients. In four patients no predisposing cardiac disease nor any operative or postoperative complication could be found to account for the occurrence of the tachycardia.
COURSE OF ARRHYTHMIAS

Onset and Duration
In Digitalization was effected by intramuscular administration in nine patients, five of whom were given digitoxill, three Digalen and one lanatoside C. Of the three given the full digitalizing dose in the first injection, one reverted to normal sinus rhythm within 12 to 48 hours, one in 48 hours, and in one the arrhythmia persisted. One patient given intramuscular digitoxin in three 0.4 mg. injections over a 10-hour period reverted to normal sinus rhythm after the last dose. In five patients digitalization, was spread over a 12 to 24 hour period; in two of these normal sinus rhythm was established 12 to 48 hours later; in two the arrhythmia disappeared more than 48 hours later, and one remained arrhythmic. The glycoside was given by mouth inl 11 instances, 10 receiving 1.2 mg. or more of digitoxin and one 1.5 Gm. of digitalis leaf. Of the three given the full dose immediately, one established normal sinus rhythm within 12 hours, another in two days, and in the third the abnormal rhythm persisted. Four were digitalized over a 1 to 12-hour period with reversion to normal sinus rhythm wvithini 12 hours after digitalization in one patient, inl 12 to 48 hours in one, in 10 days inl another; inl the fourth the arrhythmia persisted. Four were digitalized slowly over a 12 to 36-hour period, one reverting 24 hours after full digitalization, two in two and five days respectively, and one remaining arrhythmic.
Thirteen patients developed (ongestive heart failure: three before and 10 after the onset of arrhythmia. Ten were given a cardiac glycoside, all in adequate dosage. In four of these the heart failure cleared. In two the heart failure had cleared before the establishment of normal sinus rhythm; in one the heart failure disappeared rapidly after cessation of the arrhythmia. One patient manifested signs of congestive heart failure for six days after reversion to normal sinus rhythm. Two patients had persistent evidence of congestive heart failure despite adequate digitalization and control of their arrhythmia. Four patients were apparently unaffected by the administration of digitalis, both the arrhythmia and the congestive heart failure persisting until death. Three patients with congestive heart failure were not given digitalis; all died 3 to 12 weeks postoperatively with the persistent arrhythmia and heart failure being the major cause of death. Four of the 42 patients receiving a digitalis preparation were intoxicated by the drug; two of these developed an arrhythmia concomitant with the intoxication. One patient who had been completely digitalized one week previously was mistakenly given 6 cat units of folia digitalis within four days and developed supraventricular tachycardia during the ensuing period of nausea and vomiting. Through error, another patient was given 10 mg. of digitoxin instead of 1 mg. and six hours later developed auricular fibrillation. Both of these arrhythmias reverted promptly when digitalis was stopped and quinidine given.
Quinidine. Following the onset of arrhythmia in 22 patients a quinidine preparation, most frequently quinidine sulfate, was ac'-ministered. The intramuscular route was used in one patient to whom a total of 0.6 Gm. was given with reversion of the arrhythmia within 12 hours after the institution of therapy.
Quinidine was given by mouth to 21 patients, 11 of whom simultaneously received other cardiac drugs. Normal sinus rhythm appeared in 15, and quinidine was felt to be primarily responsible for the reversion. Dosage varied from 0.4 to 18.0 Gm. given over a period of from eight hours to 11 days. The average dose was 3.9 Gm. given over an average time of 50 hours. In most patients the dose of quinidine was less than optimal, and no instance of cinchonism was encountered.
Eight patients with arrhythmia were treated with quinidine alone; two reverted to normal sinus rhythm within 12 to 24 hours, three within 24 to 48 hours, and in three instances the arrhythmia persisted. Seven patients who had been treated with digitalis glycosides without reversion developed normal sinus rhythm when quinidine was given, four in 12 to 24 hours, two within 24 to 48 hours, one requiring four days. There were five instances in which the administration both of quinidine and of digitalis failed to control the abnormal rhythm. Maintenance doses of quinidine ranging from 0.2 Gm. to 1.6 Gm. per 24 hours were given to 13 patients, but the arrhythmia recurred in four instances; the maintenance dosages of quinidine in these four patients were 0.9 Gm., 1.2 Gm., 1.2 Gm. and 1.6 Gm. per 24 hours. Four of nine patients not getting maintenance doses of quinidine had recurrence of arrhythmia.
Other Therapy
Vagal stimulation by means of ocular or carotid sinus pressure was recorded as having been tried in six patients, with a transient response in one; subsequently cardiac drug therapy accomplished reversion of the arrhythmia in all six.
Two patients received procaine intravenously (0.5 Gm.). In one, auricular tachycardia reverted to sinus rhythm within four hours; in the other auricular flutter persisted. Two patients received procaine amide. One with auricular tachycardia was unaffected by 0.5 Gm. intravenously; one with multiple arrhythmias reverted within three days, during which he received a total of 3.5 Gm. orally. Two patients received Prostigmin subcutaneously, and one with nodal tachycardia reverted within two hours after the administration of 1.0 mg. but the arrhythmia recurred three days later and did not respond subsequently to 0.5 mg. The other, a patient with auricular tachycardia, received 0.5 mg. twice without definite response. Three patients were given acetylcholine intravenously, and one with supraventricular tachycardia reverted immediately after having received 20 mg.; one instance of auricular tachycardia and one of auricular flutter did not respond respectively to 10, 20, 30 or 40 mg. doses given separately over a 12 hour period.
Uncontrolled Arrhythmias
Of the 12 uncontrolled arrhythmias four were multiple types, three were auricular fibrillation, three were nodal tachycardia and two were unidentified supraventricular tachycardias. Some of the factors apparently contributing to persistent arrhythmia include organic heart disease noted preoperatively (10 patients), postoperative extracardiac complications with stormy course (six patients), preceding postoperative myocardial infarction and heart failure (four patients), and probably inadequate cardiac drug therapy (eight patients). Eight of these 12 patients developed heart failure; in two its onset preceded the arrhythmia. Four died primarily of heart failure; five died of infection, one of malignancy and one of cardiac arrest. Of the three patients with auricular fibrillation, two were receiving 0.2 mg. of digitoxin daily; the ventricular rate of one was consistently above 100 per minute while that of the other was below 100 per minute. In seven of the nine patients with other types of arrhythmias the heart rates were faster than 100 per minute terminally. In the remaining two patients these data were not recorded.
End Results
Twenty of the 50 patients were living at the time of last follow-up; the duration of this period postoperatively ranged up to 38 months, with an average of 12 months. None of these patients showed evidence of cardiac arrhythmia or of heart failure. Eight were maintained on digitoxin, and none was taking quinidine.
Thirty of the 50 patients have died, all within two years postoperatively, with an average postoperative survival of five and two-tenths months. At the time of death, nine had no evidence of cardiac failure or arrhythmia; four had the arrhythmia only; two had heart failure with normal rhythm; 11 had heart failure and arrhythmia. The cardiac status of four patients at the time of death was unknown. Ten patients were taking digitoxin. Nine of the 30 deaths were due to cardiac disease; persistent cardiac arrhythmia with ensuing heart failure was the major factor in the death of six of these; of the remaining three, two died of myocardial infarction and one of cardiac arrest. Six deaths were due to malignancies, six to infection, four to pulmonary infarctions and the other five to various extracardiac diseases.
DISCUSSION
Although it is difficult to anticipate which patients will develop cardiac arrhythmias as a complication of surgery, 79 per cent of our patients had preoperative evidence of heart disease and/or clinically evident auricular or ventricular premature contractions. Preventive measures should include preoperative control of the extrasystoles supplemented by the use of digitalis when indicated.
Intraoperative systolic hypotension to 100 mm. Hg or less and postoperative cardiopulmonary complications appeared to be causally related to the onset of the arrhythmias. Anemia, fever, and parenteral administration of fluids or blood did not seem to be contributory. Combinations of these and other factors listed elsewhere appeared to be operative as suggested by the fact that 45 per cent of the arrhythmias developed after the second postoperative day.
Twenty per cent of the abnormal rhythms had their onset during the operation; trauma to the heart or to related autonomically innervated structures, cardiac arrest and pulmonary edema were possible precipitating causes in 5 of the 11 instances. The type of anesthesia given did not appear to be of import etiologically, but a significant fall in systolic blood pressure to less than 100 mm. Hg was noted in 63 per cent. The possible importance of hypoxia or anoxia could not be evaluated.
In the present study the cardiac arrhythmias responded slowly to therapy probably because of the serious organic disease responsible for their etiology. Vagal SUMARLO ESPAROL Taquicardia supraventricular postoperatoria persistente no obstante tratamiento adequado es un signo de pronostico malo y decompensaci61n cardfaca debida o asociada con la arritmia responde pobremente a tratamiento. De los 12 pacientes (24 por ciente) no respondieron a tratamiento, ocho desarrollaron decompensacion cardiaca, cinco muriendo como resultado. Los factores preoperatorios, intraoperatorios y postoperatorios que contribuyen como causa a esta complicacion se revisan, y la terapia, curso y resultados se discuten.
